Literature DB >> 18760561

A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases.

E Stoeckle1, J M Coindre, M Longy, M Bui Nguyen Binh, G Kantor, M Kind, C Tunon de Lara, A Avril, F Bonichon, B Nguyen Bui.   

Abstract

BACKGROUND: The management of desmoid tumours, previously based on strategies employed for sarcomas, should be reassessed, given the morbidity of interventions used in their treatment.
METHODS: Long-term follow-up (median 123 months) of a series of 106 treated patients with 69 primary and 37 recurrent desmoids, in order to study natural history and outcome.
RESULTS: Desmoids typically evolved actively over a median period of 3 years, and stabilised thereafter. Recurrences or progression most commonly occurred between 14 and 17 months. Risk factors for recurrence were presentation (primary vs. recurrent), gender, tumour location and resection margins. However, survival was independent from these factors, with equivalent survival whether resection had been performed or not. Tumour control and functional outcome depended on location and presentation. Functional impairment was proportional to number of operations and whether patients had received radiotherapy. Recurrences were observed in 12/23 patients after radiotherapy.
CONCLUSION: Desmoids are relatively indolent tumours needing different approaches than sarcomas. Direct surgery is advisable only in primary lower trunk wall/girdle locations. Wait-and-see and medical treatment is preferable in other types of presentations.

Entities:  

Mesh:

Year:  2008        PMID: 18760561     DOI: 10.1016/j.ejso.2008.06.1495

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  39 in total

1.  Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.

Authors:  Daniel Robert Quast; Ralph Schneider; Emanuel Burdzik; Steffen Hoppe; Gabriela Möslein
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

2.  Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatoses.

Authors:  Sarah J Aitken; Nadège Presneau; Sangeetha Kalimuthu; Palma Dileo; Fitim Berisha; Roberto Tirabosco; M Fernanda Amary; Adrienne M Flanagan
Journal:  Virchows Arch       Date:  2015-04-03       Impact factor: 4.064

3.  Successful treatment of an intra-abdominal desmoid tumor with irinotecan, fluorouracil, and leucovorin plus bevacizumab in a patient with familial adenomatous polyposis.

Authors:  Leonardo Atem Costa; Loureno Cezana; Thiago Bueno Oliveira; Aldo Lourenço Dettino; Maria Dirlei Begnami; Clovis Antônio Pinto; Marcello Ferretti Fanelli; Celso Abdon Mello
Journal:  Int J Colorectal Dis       Date:  2011-04-30       Impact factor: 2.571

4.  Prognostic factors in desmoid tumours: an example of translational oncology.

Authors:  Soledad Gallego Melcón
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

5.  Postoperative radiotherapy in primary resectable desmoid tumors of the neck: a case-control study.

Authors:  Xiaoshuang Niu; Rui Jiang; Chaosu Hu
Journal:  Strahlenther Onkol       Date:  2019-06-06       Impact factor: 3.621

6.  Cytoreductive strategy for multiple intra-abdominal and abdominal wall desmoid tumors in familial adenomatous polyposis: report of three cases.

Authors:  Koji Tanaka; Yuji Toiyama; Yoshinaga Okugawa; Junichiro Hiro; Aya Kawamoto; Yasuhiro Inoue; Keiichi Uchida; Toshimitsu Araki; Yasuhiko Mohri; Masato Kusunoki
Journal:  Clin J Gastroenterol       Date:  2012-09-08

7.  Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.

Authors:  Nicholas A Mignemi; Doha M Itani; John H Fasig; Vicki L Keedy; Kenneth R Hande; Brent W Whited; Kelly C Homlar; Hernan Correa; Cheryl M Coffin; Jennifer O Black; Yajun Yi; Jennifer L Halpern; Ginger E Holt; Herbert S Schwartz; Jonathan G Schoenecker; Justin M M Cates
Journal:  Cancer Sci       Date:  2012-11-15       Impact factor: 6.716

8.  Desmoid Tumours in Familial Adenomatous Polyposis: Review of 17 Patients from a Portuguese Tertiary Center.

Authors:  Marco Santos; Anabela Rocha; Vilma Martins; Marisa Santos
Journal:  J Clin Diagn Res       Date:  2016-10-01

9.  Prognostic factors for second recurrence after surgical resection of recurrent desmoid-type fibromatosis.

Authors:  Justin M M Cates
Journal:  Pathol Oncol Res       Date:  2015-04-29       Impact factor: 3.201

10.  A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis.

Authors:  Jean-Emmanuel Kurtz; Irène Asmane; Anne-Claire Voegeli; Agnès Neuville; Armelle Dufresne; Valère Litique; Christine Chevreau; Jean-Pierre Bergerat
Journal:  Sarcoma       Date:  2010-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.